Voglistar GM2 Tab

Composition

Voglibose 0.2 mg + Metformin Hydrochloride 500 mg (as sustained release) + Glimepiride 2 mg

Uses of Voglistar GM2 Tab

Type 2 diabetes mellitus (when diet and exercise alone are not enough), especially in patients requiring triple therapy to control post‑meal and fasting blood glucose

• •Controls post‑meal glucose spikes
• •Lowers fasting blood glucose
• •Improves insulin sensitivity
• •Helps achieve better HbA1c control in type 2 diabetes

How it works

Voglibose inhibits intestinal alpha‑glucosidase enzymes, delaying carbohydrate digestion and reducing post‑meal blood glucose spikes. Metformin decreases hepatic glucose production and improves insulin sensitivity. Glimepiride stimulates insulin release from pancreatic beta cells to lower blood glucose.

Directions for use

Tablet (oral). Take exactly as prescribed, usually once daily with the first main meal; swallow whole with water (do not crush/chew as it contains sustained‑release metformin). Follow diet/exercise advice and monitor blood glucose regularly.

Side effects

Common side effects of Voglistar GM2 Tab may include:

• •Hypoglycaemia
• •nausea
• •vomiting
• •diarrhoea
• •abdominal pain
• •